DE2740678A1 - 1-amino-2-hydroxy-3-heterocycloxypropane - Google Patents
1-amino-2-hydroxy-3-heterocycloxypropaneInfo
- Publication number
- DE2740678A1 DE2740678A1 DE19772740678 DE2740678A DE2740678A1 DE 2740678 A1 DE2740678 A1 DE 2740678A1 DE 19772740678 DE19772740678 DE 19772740678 DE 2740678 A DE2740678 A DE 2740678A DE 2740678 A1 DE2740678 A1 DE 2740678A1
- Authority
- DE
- Germany
- Prior art keywords
- group
- yloxy
- formula
- propanol
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1263576A CH607585A5 (en) | 1976-10-05 | 1976-10-05 | Process for the preparation of 2-[3'-(2-(3,4-dimethoxy-phenyl)ethylamino)-2'-hydroxypropoxy]-3-cyanop yridine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2740678A1 true DE2740678A1 (de) | 1978-04-06 |
Family
ID=4384944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19772740678 Withdrawn DE2740678A1 (de) | 1976-10-05 | 1977-09-09 | 1-amino-2-hydroxy-3-heterocycloxypropane |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS5350177A (no) |
| AT (1) | AT358037B (no) |
| AU (1) | AU514676B2 (no) |
| BE (1) | BE858867A (no) |
| CA (1) | CA1105021A (no) |
| CH (1) | CH607585A5 (no) |
| DE (1) | DE2740678A1 (no) |
| DK (1) | DK402877A (no) |
| ES (1) | ES462389A1 (no) |
| FI (1) | FI772681A (no) |
| FR (1) | FR2367065A1 (no) |
| GB (1) | GB1591723A (no) |
| GR (1) | GR71677B (no) |
| IE (1) | IE45692B1 (no) |
| IL (1) | IL53013A (no) |
| NL (1) | NL7710394A (no) |
| NO (1) | NO773125L (no) |
| NZ (1) | NZ185267A (no) |
| PT (1) | PT67048B (no) |
| SE (1) | SE7710250L (no) |
| ZA (1) | ZA775698B (no) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001036412A1 (en) * | 1999-11-15 | 2001-05-25 | Eli Lilly And Company | Process for the preparation of aryloxy propanolamines |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK267779A (da) * | 1978-06-27 | 1979-12-28 | Merck & Co Inc | Fr&mgangsmaade til fremstilling af n-aralkylamino-propoxycyanopyridiner |
| US4210653A (en) * | 1978-06-27 | 1980-07-01 | Merck & Co., Inc. | Pyridyloxypropanolamines |
| US4208416A (en) * | 1978-06-27 | 1980-06-17 | Merck & Co., Inc. | N-Aralkyl containing cyanopyridines |
| GB8510146D0 (en) * | 1985-04-20 | 1985-05-30 | Smith Kline French Lab | Chemical compounds & processes |
| DE3776011D1 (de) * | 1986-06-30 | 1992-02-27 | Toyo Jozo Kk | 2-substituierte alkoxy-3-substituierte pyrazine. |
-
1976
- 1976-10-05 CH CH1263576A patent/CH607585A5/xx not_active IP Right Cessation
-
1977
- 1977-09-09 DK DK402877A patent/DK402877A/da unknown
- 1977-09-09 NO NO773125A patent/NO773125L/no unknown
- 1977-09-09 DE DE19772740678 patent/DE2740678A1/de not_active Withdrawn
- 1977-09-09 AT AT648777A patent/AT358037B/de not_active IP Right Cessation
- 1977-09-12 FI FI772681A patent/FI772681A/fi not_active Application Discontinuation
- 1977-09-13 SE SE7710250A patent/SE7710250L/xx not_active Application Discontinuation
- 1977-09-15 ES ES462389A patent/ES462389A1/es not_active Expired
- 1977-09-16 FR FR7728037A patent/FR2367065A1/fr active Granted
- 1977-09-19 JP JP11169877A patent/JPS5350177A/ja active Pending
- 1977-09-19 PT PT67048A patent/PT67048B/pt unknown
- 1977-09-20 GB GB39204/77A patent/GB1591723A/en not_active Expired
- 1977-09-20 BE BE181044A patent/BE858867A/xx not_active IP Right Cessation
- 1977-09-22 IE IE1938/77A patent/IE45692B1/en unknown
- 1977-09-22 NL NL7710394A patent/NL7710394A/xx not_active Application Discontinuation
- 1977-09-23 ZA ZA00775698A patent/ZA775698B/xx unknown
- 1977-09-23 CA CA287,391A patent/CA1105021A/en not_active Expired
- 1977-09-26 NZ NZ185267A patent/NZ185267A/xx unknown
- 1977-09-26 AU AU29125/77A patent/AU514676B2/en not_active Expired
- 1977-09-28 IL IL53013A patent/IL53013A/xx unknown
- 1977-09-29 GR GR54455A patent/GR71677B/el unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001036412A1 (en) * | 1999-11-15 | 2001-05-25 | Eli Lilly And Company | Process for the preparation of aryloxy propanolamines |
Also Published As
| Publication number | Publication date |
|---|---|
| CA1105021A (en) | 1981-07-14 |
| BE858867A (fr) | 1978-03-20 |
| AT358037B (de) | 1980-08-11 |
| IE45692L (en) | 1978-04-05 |
| ATA648777A (de) | 1980-01-15 |
| AU514676B2 (en) | 1981-02-19 |
| CH607585A5 (en) | 1978-09-15 |
| JPS5350177A (en) | 1978-05-08 |
| PT67048B (de) | 1979-02-16 |
| AU2912577A (en) | 1979-04-05 |
| IL53013A (en) | 1981-09-13 |
| ZA775698B (en) | 1978-05-30 |
| NO773125L (no) | 1978-04-06 |
| PT67048A (de) | 1977-10-01 |
| IE45692B1 (en) | 1982-10-20 |
| IL53013A0 (en) | 1977-11-30 |
| FI772681A (fi) | 1978-04-06 |
| DK402877A (da) | 1978-04-06 |
| FR2367065A1 (fr) | 1978-05-05 |
| NZ185267A (en) | 1979-07-11 |
| GB1591723A (en) | 1981-06-24 |
| FR2367065B1 (no) | 1980-10-10 |
| GR71677B (no) | 1983-06-21 |
| SE7710250L (sv) | 1978-04-06 |
| ES462389A1 (es) | 1978-07-01 |
| NL7710394A (nl) | 1978-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0004920B1 (de) | Carbazolyl-(4)-oxy-propanolamin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2700193A1 (de) | Veraetherte hydroxy-benzodiheterocyclen | |
| DE2520910A1 (de) | Cyclisch substituierte derivate des 1-amino-2-propanol | |
| DE2738477C2 (no) | ||
| EP0124476A1 (de) | Carboxamide, Verfahren zur Herstellung und pharmazeutische Präparate, die diese enthalten | |
| DE2100323A1 (de) | Neue Amine und Verfahren zu ihrer Herstellung | |
| DE2740678A1 (de) | 1-amino-2-hydroxy-3-heterocycloxypropane | |
| DE3119796A1 (de) | Substituierte tryptaminderivate von thienyloxpropanolaminen, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen sowie ihre verwendung | |
| CH636858A5 (de) | Verfahren zur herstellung neuer phenylazacycloalkane. | |
| DE3151201A1 (de) | Substituierte phenoxyalkanolamine und phenoxyalkanol-cycloalkylamine, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische zubereitungen und zwischenprodukte | |
| DE2400693A1 (de) | Neue amine und verfahren zu ihrer herstellung | |
| DE2417464A1 (de) | Neue amine und verfahren zu ihrer herstellung | |
| DE2409313A1 (de) | Neue pyrrolyl-verbindungen und verfahren zu ihrer herstellung | |
| DE3314196A1 (de) | Heterocyclylaether | |
| DE2507902A1 (de) | Neue amine und verfahren zu ihrer herstellung | |
| DD297814A5 (de) | Glycerolderivat und seine pharmakologische anwendung | |
| DD157796A5 (de) | Verfahren zur herstellung neuer derivate des 2-amino-aethanols | |
| EP0096006A2 (de) | 3-(Ureidocyclohexylamino)-propan-1,2-diolderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung | |
| EP0003758A1 (de) | Verätherte Hydroxy-benzodiheterocyclen und ihre Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate | |
| DD202691A5 (de) | Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols | |
| EP0069838A1 (de) | Aralkylaminoethoxysalicylamide und deren pharmazeutische Verwendung | |
| EP0239533B1 (de) | Pyridin-Derivate | |
| EP0102929B1 (de) | Propylamin-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung | |
| AT360992B (de) | Verfahren zur herstellung neuer phenylazacyclo- alkane und von deren salzen und optisch aktiven verbindungen | |
| AT358042B (de) | Verfahren zur herstellung neuer 1-amino-2- -hydroxy-3-heterocyclyloxy-propane und ihrer salze |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8130 | Withdrawal |